Last updated: 2026-10-13 23:36:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
CryoPort, Inc. (CYRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $16.95, with a market capitalisation of $878.76M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.61 to $18.36. This page covers its latest market performance, valuation, price trends and company information.
$878.76M | |
$17.11 | |
$86.30 | |
$1.03 | |
$16.84 | |
486.61K | |
643.98K | |
-- | |
$18.36 | |
$7.61 | |
-- | |
-- |
CryoPort, Inc. (CYRX) is trading at $16.95 in after-hours trading as of 2026-10-13 23:31:00, up 0.65% ($0.11) from the regular-session close of $16.84.
After-hours trading shows how investors are pricing CYRX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, CryoPort, Inc. (CYRX) moved from $17.43 to $16.95, representing a decline of 2.77% ($0.48).
The stock traded between $16.53 and $18.36 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 941.31 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 86.9%
CYRX is currently trading at $16.95, placing it 86.9% of the way from its 52-week low of $7.61 to its 52-week high of $18.36. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 738 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CryoPort, Inc. (CYRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.